Kymera Therapeutics Inc.

NASDAQ: KYMR
Share price (12/20/24): $40.66
Market cap (12/20/24): $2.633 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Automatic shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Esposito Pamela

Esposito Pamela

Atlas Venture Fund X, L.P.

Avoro Capital Advisors LLC

Price T Rowe Associates Inc

News Filter

Announces Third Quarter 2024 Financial Results and Provides a Business Update

Announces Proposed Public Offering

Announces Second Quarter 2024 Financial Results and Provides a Business Update

Announces Expansion of KT-474 (SAR444656) HS and AD Phase 2 Studies Following Interim Review of Safety and Efficacy

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC